Your browser doesn't support javascript.
loading
PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity.
LaFleur, Martin W; Nguyen, Thao H; Coxe, Matthew A; Miller, Brian C; Yates, Kathleen B; Gillis, Jacob E; Sen, Debattama R; Gaudiano, Emily F; Al Abosy, Rose; Freeman, Gordon J; Haining, W Nicholas; Sharpe, Arlene H.
Afiliação
  • LaFleur MW; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Nguyen TH; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Coxe MA; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Miller BC; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.
  • Yates KB; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Gillis JE; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Sen DR; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Gaudiano EF; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Al Abosy R; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Freeman GJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Haining WN; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Sharpe AH; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Nat Immunol ; 20(10): 1335-1347, 2019 10.
Article em En | MEDLINE | ID: mdl-31527834
CD8+ T cell exhaustion is a state of dysfunction acquired in chronic viral infection and cancer, characterized by the formation of Slamf6+ progenitor exhausted and Tim-3+ terminally exhausted subpopulations through unknown mechanisms. Here we establish the phosphatase PTPN2 as a new regulator of the differentiation of the terminally exhausted subpopulation that functions by attenuating type 1 interferon signaling. Deletion of Ptpn2 in CD8+ T cells increased the generation, proliferative capacity and cytotoxicity of Tim-3+ cells without altering Slamf6+ numbers during lymphocytic choriomeningitis virus clone 13 infection. Likewise, Ptpn2 deletion in CD8+ T cells enhanced Tim-3+ anti-tumor responses and improved tumor control. Deletion of Ptpn2 throughout the immune system resulted in MC38 tumor clearance and improved programmed cell death-1 checkpoint blockade responses to B16 tumors. Our results indicate that increasing the number of cytotoxic Tim-3+CD8+ T cells can promote effective anti-tumor immunity and implicate PTPN2 in immune cells as an attractive cancer immunotherapy target.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Adenocarcinoma / Neoplasias do Colo / Linfócitos T CD8-Positivos / Células Progenitoras Linfoides / Proteína Tirosina Fosfatase não Receptora Tipo 2 / Imunoterapia / Coriomeningite Linfocítica / Vírus da Coriomeningite Linfocítica / Melanoma Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Adenocarcinoma / Neoplasias do Colo / Linfócitos T CD8-Positivos / Células Progenitoras Linfoides / Proteína Tirosina Fosfatase não Receptora Tipo 2 / Imunoterapia / Coriomeningite Linfocítica / Vírus da Coriomeningite Linfocítica / Melanoma Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos